Pomegranate Peel Extract Sensitizes Hepatocellular Carcinoma Cells to Ionizing Radiation, Induces Apoptosis and Inhibits MAPK, JAK/STAT3, β-Catenin/NOTCH, and SOCS3 Signaling

Apoptotic activity of genipin in human oral squamous cell carcinoma in vitro by regulating STAT3 signaling

Genipin, a natural compound derived from the fruit of Gardenia jasminoides Ellis, was reported to have activity against various cancer types. In this study, we determined the underlying mechanism for genipin-induced cell death in human oral squamous cell carcinoma (OSCC). The growth-inhibitory effects of genipin in human OSCC cells was examined by the Cell Counting Kit-8 and soft agar assays. The effects of genipin on apoptosis were assessed by nuclear morphological changes by 4',6-diamidino-2-phenylindole staining, measurement of the sub-G1 population, and Annexin V-fluorescein isothiocyanate/propidium iodide double staining. The underlying mechanism of genipin activity was analyzed by western blot analysis, subcellular fractionation of the nucleus and cytoplasm, immunocytochemistry, and quantitative real-time polymerase chain reaction. Genipin inhibited the growth of OSCC cells and induced apoptosis, which was mediated by a caspase-dependent pathway. Genipin reduced the phosphorylation of signal transducer and activator of transcription 3 (STAT3) at Tyr705 and its nuclear localization. Furthermore, inhibition of p-STAT3Tyr705 levels following genipin treatment was required for the reduction of survivin and myeloid cell leukemia-1 (Mcl-1) expression, leading to apoptotic cell death. The genipin-mediated reduction in survivin and Mcl-1 expression was caused by transcriptional and/or posttranslational regulatory mechanisms. The results provide insight into the regulatory mechanism by which genipin induces apoptotic cell death through the abrogation of nuclear STAT3 phosphorylation and suggest that genipin may represent a potential therapeutic option for the treatment of human OSCC.

A review of experimental and clinical studies on the therapeutic effects of pomegranate (Punica granatum) on non-alcoholic fatty liver disease: Focus on oxidative stress and inflammation

Non-alcoholic fatty liver disease (NAFLD) is frequently linked to metabolic disorders and is prevalent in obese and diabetic patients. The pathophysiology of NAFLD involves multiple factors, including insulin resistance (IR), oxidative stress (OS), inflammation, and genetic predisposition. Recently, there has been an emphasis on the use of herbal remedies with many people around the world resorting to phytonutrients or nutraceuticals for treatment of numerous health challenges in various national healthcare settings. Pomegranate (Punica granatum) parts, such as juice, peel, seed and flower, have high polyphenol content and is well known for its antioxidant capabilities. Pomegranate polyphenols, such as hydrolyzable tannins, anthocyanins, and flavonoids, have high antioxidant capabilities that can help lower the OS and inflammation associated with NAFLD. The study aimed to investigate whether pomegranate parts could attenuate OS, inflammation, and other risk factors associated with NAFLD, and ultimately prevent the development of the disease. The findings of this study revealed that: 1. pomegranate juice contains hypoglycemic qualities that can assist manage blood sugar levels, which is vital for avoiding and treating NAFLD. 2. Polyphenols from pomegranate flowers increase paraoxonase 1 (PON1) mRNA and protein levels in the liver, which can help protect liver enzymes and prevent NAFLD. 3. Punicalagin (PU) is one of the major ellagitannins found in pomegranate, and PU-enriched pomegranate extract (PE) has been shown to inhibit HFD-induced hyperlipidemia and hepatic lipid deposition in rats. 4. Pomegranate fruit consumption, which is high in antioxidants, can decrease the activity of AST and ALT (markers of liver damage), lower TNF-α (a marker of inflammation), and improve overall antioxidant capacity in NAFLD patients. Overall, the polyphenols in pomegranate extracts have antioxidant, anti-inflammatory, hypoglycemic, and protective effects on liver enzymes, which can help prevent and manage NAFLD effects on liver enzymes, which can help prevent and manage NAFLD.

Antitumoral properties of the pomegranate peel and blueberry extracts against tongue carcinoma (in vitro study)

Background

Oral squamous cell carcinoma (OSCC) is one of the most common cancers globally. Considering the drawbacks of the traditional treatment phytochemicals have been introduced to the research field with consideration of their minimal, or no side effects and good efficacy against cancer cells. Pomegranate peel and blueberries are very well-known phytochemicals in this context.

Material and methods

Methanolic extracts are prepared from both pomegranate peel (PPE) and blueberry (BE) dried powders. The antioxidant content was determined by ORAC assay for both extracts. The cytotoxic levels of the extracts and IC50 on the HNO-97 cell line were defined using the colorimetric SRB assay. Then flow cytometric apoptosis analysis of the IC50 of both extracts was performed. Finally, an investigation of the metastasis through the wound healing assay was performed for both extracts.

Results

A significant difference in the antioxidant content was found between PPE and BE ethanolic extracts. The Ic50 for the PPE-treated cell line was 73.35 µg/ml while the BE showed it at 525.38 µg/ml with a significant difference between them. Both PPE and BE showed significant induction of cancer cell apoptosis with much better results with PPE treatment. The wound healing assay showed significant inhibition of cell migration when treated with PPE while there was not any significant effect on cell migration when treated with BE.

Conclusion

With the consideration that, the Phytochemicals used are well-known fruits with no harm on normal tissues. Low doses of PPE exert incredibly significant alteration in the HNO-97 tongue cancer cell proliferation, inducing apoptosis and inhibition of cancer cell migration. Meanwhile, treatment with BE needs much higher doses for showing anti-proliferative properties of cancer cells and induce cancer cell apoptosis. This gives promising results for further investigations about using them as a treatment or adjunctive treatment for oral cancer cases.